Startup India Government of India
Snapan's Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹2.85 Cr
▲ 129% YoY
Net loss · FY 2024
₹3.04 Lakh
Net margin -1.1%
EBITDA · FY 2024
-₹11,337
EBITDA margin 0%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹13 Lakh
Issued & subscribed
Open charges
₹54 Lakh
Secured borrowings
Company age
4 yrs
Est. 2022
Directors on board
4
As per MCA filings
About Snapan's Pharma Private Limited
Data last updated:
Snapan's Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 23 June 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85300TG2022PTC164013.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹13 Lakh. It is led by directors including Mohd Khaja Riazuddin and Mallikarjun Rao Polkampally.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Door.No.5 – 4 – 786/1/3 Abids South, Hyderabad, Telangana, India – 500001.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.85 Cr, a growth of 129% compared to the previous year. For the same year it recorded a net loss of ₹3.04 Lakh (net margin -1.1%) and EBITDA of -₹11,337 (EBITDA margin 0%).
As per MCA filings, the company has open charges of ₹54 Lakh on record. Court records list 4 cases involving the company, including 4 filed against it; 1 case is pending.
Snapan's Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0080332). For more details, the company can be reached via its website snapanspharma.com.
Company details
CIN U85300TG2022PTC164013
Registration Number 164013
Incorporation Date 23 June 2022
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-TS-02-0080332
Key People
Mohd Khaja Riazuddin Director Mallikarjun Rao Polkampally Director Veldanda Lavanya Director Recognitions & Rankings of Snapan's Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-02-0080332
Contact details
Snapan's Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is snapanspharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressDoor.No.5 – 4 – 786/1/3 Abids South, Hyderabad, Telangana, India – 500001
- IndustryPharma, Animal Pharmaceuticals & Healthcare
To see the full contact details of Snapan's Pharma Private Limited, buy the company report.
Comprehensive company report
Snapan's Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Snapan's Pharma is professional, scientific and technical. In detail, this covers veterinary activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M8 | Veterinary activities |
To see the full business activity and turnover split of Snapan's Pharma Private Limited, buy the company report.
Financials of Snapan's Pharma Private Limited
FY 2024 filings availableSnapan's Pharma Private Limited reported revenue of ₹2.85 Cr (up 129% YoY) for FY 2024.
Revenue · FY 2024
₹2.85 Cr ▲ 129%
Net loss · FY 2024
₹3.04 Lakh margin -1.1%
EBITDA · FY 2024
-₹11,337 margin 0%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 129%
EBITDA CAGR growth
1 year
▼ 104%
Revenue rose 129% in the latest year. EBITDA fell 104% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹11,337 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹3.04 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0% | |
| Net Profit Margin | -1.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Snapan's Pharma Private Limited, buy the company report.
Board of directors of Snapan's Pharma Private Limited
Snapan's Pharma has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohd Khaja Riazuddin Also directs: Sai Lintex India Private Limited | Director | 23 Jun 2022 | 4 Years 4 Months | Current |
| Mallikarjun Rao Polkampally | Director | 23 Jun 2022 | 4 Years 4 Months | Current |
| Veldanda Lavanya | Director | 23 Jun 2022 | 4 Years 4 Months | Current |
| Shaik Zarina Banu Also directs: Nadishira Textiles Private Limited | Director | 23 Jun 2022 | 4 Years 4 Months | Current |
Auditor
Snapan's Pharma Private Limited is audited by DSRK & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DSRK & ASSOCIATES | FY 2023 | 012914S |
Shareholding
The shareholding of Snapan's Pharma Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Snapan's Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹54 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Feb 2024 | 100896591 | Indian Bank | ₹54 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Snapan's Pharma Private Limited has 4 court cases on record: 4 filed against it. 1 case is pending and 3 are disposed.
Total cases
4
Filed against the company
4
Pending
1
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 4 | 1 |
Cases on record (3 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Zenex Animal Health India Pvt. Ltd | Pending |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Zenex Animal Health India Pvt. Ltd | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed against the company by Zenex Animal Health India Pvt. Ltd | Disposed |
To see the full case history of Snapan's Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Snapan's Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Snapan's Pharma Private Limited has 1 active EPFO establishment as of Mar 31, 2024.
Active EPFO establishments
1
GST
No GST registration is on our record for Snapan's Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Snapan's Pharma Private Limited has 5 board changes on record since 2022: 4 appointments and 1 cessation. The latest: Vijayalakshmi Koduru ceased to be Director on 25 Oct 2022.
AGM
Snapan'S Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Snapan'S Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Indian Bank amounted to Rs. 54.00 Lakh with Charge ID 100896591 was registered on 08 Feb 2024.
Ceased
Vijayalakshmi Koduru ceased to be Director.
Appointed
Mallikarjun Rao Polkampally was appointed as Director.
Appointed
Mohd Khaja Riazuddin was appointed as Director.
Appointed
Shaik Zarina Banu was appointed as Director.
Appointed
Veldanda Lavanya was appointed as Director.
Incorporation
23 Jun 2022
Snapan'S Pharma Private Limited was registered on 23 Jun 2022 with Roc Hyderabad & aged 4 years 4 months as per MCA records.
Frequently asked questions
Snapan's Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 23 June 2022 (4+ years old) and is registered under CIN U85300TG2022PTC164013.
Snapan's Pharma has 4 current directors:
- Mohd Khaja Riazuddin - Director
- Mallikarjun Rao Polkampally - Director
- Veldanda Lavanya - Director
- Shaik Zarina Banu - Director
The latest financial statements of Snapan's Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Snapan's Pharma is U85300TG2022PTC164013. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Snapan's Pharma has 4 court cases on record: 4 filed against it. 1 is pending.
Snapan's Pharma was incorporated on 23 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
Vijayalakshmi Koduru ceased to be Director on 25 Oct 2022. Mallikarjun Rao Polkampally was appointed as Director on 23 Jun 2022. Mohd Khaja Riazuddin was appointed as Director on 23 Jun 2022. Snapan's Pharma has 5 board changes on record in total.
Yes, Snapan's Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Snapan's Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-02-0080332).
Snapan's Pharma can be reached through the website snapanspharma.com. Its registered office is in Hyderabad, Telangana, India.